Fully automated nucleic acid testing platform combines the accuracy of molecular testing with a short turnaround time, allowing same day treatment decisions and consultations with patients. The portable m-PIMA™ Analyser brings HIV early infant diagnosis and HIV viral load testing to a wide range of decentralized settings, bypassing delays and inefficiencies associated with centralized testing.
The m-PIMA™ HIV-1/2 VL test is now commercially available and has received CE-IVD marking and WHO prequalification. This product is not available in the United States.
Based on your current location, the content on this page may not be relevant for your country.